Does warfarin (target INR 2.0 to 3.0) prevent systemic emboli in patients with dilated cardiomyopathy and sinus rhythm without left ventricular thrombus?
Patients with congestive heart failure, dilated cardiomyopathy of unknown cause, in sinus rhythm, without left ventricular thrombus (based on a 51-year-old male case scenario)
Warfarin (target INR 2.0 to 3.0)
Prevention of systemic embolihard clinical
This article uses a clinical scenario of a patient with dilated cardiomyopathy in sinus rhythm to illustrate how to search the medical literature for evidence on anticoagulation.
Y o u are the attending physician on an inpatient service where a 51-year-old man is admitted with congestive heart failure o f recent onset. You find he has a dilated cardiomyopathy, the cause o f which remains unknown after a thorough evaluation. He is in sinus rhythm. The team's resident asks you whether the patient should be anticoagulated with warfarin, enough to keep his international normalized ratio from 2.0 t o 3.0, in order to prevent systemic emboli, even though his echocardiogram does not show left ventricular thrombus. You are not sure about the evidence concerning this issue, so you admit your shared knowledge gap and resolve t o search together for the relevant information.
Building similarity graph...
Analyzing shared references across papers
Loading...
Andrew D Oxman
Norwegian Institute of Public Health
JAMA
Building similarity graph...
Analyzing shared references across papers
Loading...
Andrew D Oxman (Wed,) studied this question.
synapsesocial.com/papers/69d7f88c3b601d7be3ae37bd — DOI: https://doi.org/10.1001/jama.1993.03510170083036